SP Langdon
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Chemical Synthesis and Analysis 2
- Enzyme function and inhibition 2
- DNA Repair Mechanisms 1
- Oncology 7
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- John Smyth (2 shared papers)Enrique Rozengurt (2 shared papers)T Sethi (2 shared papers)H.H. Fiebig (2 shared papers)Øystein Fodstad (2 shared papers)WR Miller (4 shared papers)J F Smyth (3 shared papers)A. Jayne Crew (2 shared papers)
- Journals
- British Journal of Cancer (6 papers)European Journal of Cancer (1 paper)PubMed (4 papers)The Journal of Pathology and Bacteriology (2 papers)
- Partner nations
- United KingdomItalyNorway
In The Last Decade
SP Langdon
11 papers receiving 452 citations
Peers
Comparison fields: 5 of 71
- Reproductive Medicine 54
- Oncology 154
- Cellular and Molecular Neuroscience 98
- Immunology and Allergy 27
- Cancer Research 50
Countries citing papers authored by SP Langdon
This map shows the geographic impact of SP Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SP Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SP Langdon more than expected).
Fields of papers citing papers by SP Langdon
This network shows the impact of papers produced by SP Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SP Langdon. The network helps show where SP Langdon may publish in the future.
Co-authors
The 25 scholars most cited alongside SP Langdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. | 1992 | 128 |
| 2 | 1990 | 77 | |
| 3 | Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. | 1992 | 74 |
| 4 | Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. | 1992 | 74 |
| 5 | 1996 | 40 | |
| 6 | 1998 | 28 | |
| 7 | 1992 | 23 | |
| 8 | Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. | 1995 | 11 |
| 9 | 1997 | 8 | |
| 10 | 1991 | 5 | |
| 11 | The Effects of Novel Carbonic Anhydrase Inhibitors on the Proliferation and Invasion of Breast and Ovarian Cancer Cells | 2013 | 1 |
| 12 | 1992 | 1 | |
| 13 | An Ex-Vivo Tumour Model Using Core Biopsy Explants Validate Carbonic Anhydrase IX (CAIX) as a Therapeutic Target in Breast Cancer | 2013 | 0 |
About SP Langdon
SP Langdon is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 13 papers that have together received 470 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chemical Synthesis and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers), Enzyme function and inhibition (2 papers), Peptidase Inhibition and Analysis (2 papers), Neuropeptides and Animal Physiology (2 papers) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Reproductive Medicine (54 citations), Oncology (154 citations), Cellular and Molecular Neuroscience (98 citations), Immunology and Allergy (27 citations) and Cancer Research (50 citations). SP Langdon has collaborated with scholars based in United Kingdom, Italy and Norway. Frequent co-authors include John Smyth, Enrique Rozengurt, T Sethi, H.H. Fiebig, Øystein Fodstad, WR Miller, J F Smyth, A. Jayne Crew, Alison Ritchie and Morwenna Muir. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, PubMed and The Journal of Pathology and Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.